2 dagen geleden - Erasmus Universiteit Rotterdam - Rotterdam
Job description We are expanding our team of Business Information Management faculty members to complement our ongoing research into this increasingly …
BackgroundThe ageing population and the increased incidence of chronic disease is imposing unparalleled financial and societal burden. There is an urgent need …
The ageing population and the increased incidence of chronic disease is imposing unparalleled financial and societal burden. There is an urgent need for a paradigm shift towards "precision medicine": a tailored, personalized approach in medicine to improve patient care and quality of life, while reducing healthcare costs. To tackle this urgent clinical challenge, a 4TU consortium has been recently established on precision medicine by the Eindhoven University of Technology (TU/e), the Delft University of Technology (TUD), the University of Twente (UT), and Wageningen University (WU). The goal of the 4TU consortium is to facilitate precision medicine by realizing breakthrough advances in medical imaging, through the synergetic collaboration of top experts in all aspects of imaging science, spanning from acquisition technology to image analysis and interpretation.
Cancer and cardiovascular disease account for about half of deaths worldwide. Although the crucial role of angiogenesis in cancer growth and cardiovascular diseases is today well-established, this complex multi-step process is not yet fully understood. At the molecular level, angiogenesis is characterized by the over-expression of specific molecules which promote the growth of new blood vessels. The resulting vascular network shows different features than normal vasculature such as increased microvascular density, tortuosity, and permeability. Novel promising drugs aim at interfering or blocking angiogenic processes. Imaging of angiogenesis holds thus promise for both improved diagnostics and therapy.
Biomedical diagnostic (BM/d) research lab at TU/e
The BM/d lab is devoted to model-based quantitative analysis of medical images and bio-signals, with the goal of improving patient care and management. In the context of angiogenesis imaging, we focus on developing novel imaging solutions able to provide structural, functional, and molecular information on angiogenesis at different spatial and temporal scale. Contrast enhanced-imaging can provide valuable information beyond structural imaging by injection of contrast agents. While contrast agents used in ultrasound remain intravascular, MRI contrast agent can cross the vascular endothelium and distribute into tissue. Assessment of the (micro)vasculature can thus be achieved by modeling and analysis of the complex hemodynamics and the different pharmacokinetics of ultrasound and MRI contrast agents. Multi-modal spatiotemporal analysis enables combining the complementary information from different modalities at different scales, proving deeper insight into the complex processes underlying angiogenesis.
Job description and requirements
In this context, we are seeking a highly motivated post-doctoral researcher with knowledge and interest in ultrasound and magnetic resonance imaging, and with a strong background in model-based image analysis. The position is available within the BM/d research lab, part of the Signal Processing Systems (SPS) group (Electrical Engineering department, TU/e), and it involves joint collaborations with the universities of the 4TU consortium, and its clinical partnerships, including the Academic Medical Center (Amsterdam) and the Erasmus Medical Center (Rotterdam). </p